RWMG
TCRT icon

Redwood Wealth Management Group’s Alaunos Therapeutics TCRT Stock Holding History

Redwood Wealth Management Group’s Portfolio TCRT Stock Details TCRT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-20
Closed -$140 – 987
2024
Q2 		$140 Buy
+20
New +$239 ﹤0.01% 1163
2024
Q1 		– Sell
-334
Closed -$3.54K – 139
2023
Q4 		$3.54K Buy
+334
New +$4.02K ﹤0.01% 142

Other funds holding TCRT

MP
MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
SWM
Sugarloaf Wealth Management Duluth, Georgia $529M AUM 14.14% 1-Year Est. Return

Redwood Wealth Management Group's TCRT Position: Q3 2024 in Review

Redwood Wealth Management Group sold out of Alaunos Therapeutics (TCRT) in Q3 2024, closing a stake of 20 shares — an estimated $140 sold.

Redwood Wealth Management Group first reported a position in TCRT in Q4 2023 and held it in 2 quarters. The position peaked at $3.54K in Q4 2023. 29 funds tracked by Wall St. Rank hold TCRT as of Q3 2024.

  • Redwood Wealth Management Group reported no remaining Alaunos Therapeutics position as of Q3 2024 after selling out during the quarter.
  • Redwood Wealth Management Group sold 20 Alaunos Therapeutics shares in Q3 2024, an estimated $140.
  • Redwood Wealth Management Group first reported a position in Alaunos Therapeutics in Q4 2023 and held it in 2 quarters.
  • Redwood Wealth Management Group's Alaunos Therapeutics position peaked at $3.54K in Q4 2023.
  • 29 funds tracked by Wall St. Rank held Alaunos Therapeutics as of Q3 2024.

Based on Redwood Wealth Management Group's 13F filing for Q3 2024, filed 13 Nov 2024.